REGENERON PHARMACEUTICALS, INC.

REGNNasdaq· Pharmaceutical Preparations

Price History

Revenue

$14.3B

▲ 1.0% YoY

Net Income

$4.5B

▲ 2.1% YoY

EPS

$41.48

▲ 8.2% YoY

Cash

$3.1B

▲ 25.3% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.